Susquehanna International Group’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-52,692
| Closed | -$5.27K | – | 13108 |
|
|
2025
Q4 | $5.27K | Sell |
52,692
-424,465
| -89% | -$270K | ﹤0.01% | 12092 |
|
|
2025
Q3 | $289K | Sell |
477,157
-109,518
| -19% | -$51.6K | ﹤0.01% | 10207 |
|
|
2025
Q2 | $183K | Buy |
586,675
+151,867
| +35% | +$58.8K | ﹤0.01% | 11303 |
|
|
2025
Q1 | $213K | Sell |
434,808
-121,193
| -22% | -$71.4K | ﹤0.01% | 10810 |
|
|
2024
Q4 | $476K | Buy |
556,001
+522,150
| +1,542% | +$3.27M | ﹤0.01% | 8780 |
|
|
2024
Q3 | $288K | Sell |
33,851
-79,068
| -70% | -$466K | ﹤0.01% | 9687 |
|
|
2024
Q2 | $527K | Sell |
112,919
-371,966
| -77% | -$1.76M | ﹤0.01% | 8145 |
|
|
2024
Q1 | $3.3M | Sell |
484,885
-82,560
| -15% | -$371K | ﹤0.01% | 4331 |
|
|
2023
Q4 | $1.9M | Buy |
567,445
+473,653
| +505% | +$1.18M | ﹤0.01% | 5465 |
|
|
2023
Q3 | $234K | Buy |
+93,792
| New | +$155K | ﹤0.01% | 9884 |
|
|
2023
Q1 | – | Sell |
-21,931
| Closed | -$16.7K | – | 12507 |
|
|
2022
Q4 | $16.7K | Sell |
21,931
-809
| -4% | -$640 | ﹤0.01% | 11824 |
|
|
2022
Q3 | $21K | Buy |
22,740
+9,664
| +74% | +$11.6K | ﹤0.01% | 12580 |
|
|
2022
Q2 | $12K | Buy |
+13,076
| New | +$21.4K | ﹤0.01% | 12474 |
|
|
2022
Q1 | – | Sell |
-60,463
| Closed | -$541K | – | 12921 |
|
|
2021
Q4 | $541K | Buy |
60,463
+8,485
| +16% | +$111K | ﹤0.01% | 8974 |
|
|
2021
Q3 | $863K | Sell |
51,978
-21,182
| -29% | -$366K | ﹤0.01% | 7951 |
|
|
2021
Q2 | $1.52M | Sell |
73,160
-16,191
| -18% | -$306K | ﹤0.01% | 6602 |
|
|
2021
Q1 | $1.68M | Buy |
89,351
+46,550
| +109% | +$1M | ﹤0.01% | 6345 |
|
|
2020
Q4 | $942K | Buy |
42,801
+28,980
| +210% | +$603K | ﹤0.01% | 6853 |
|
|
2020
Q3 | $287K | Buy |
+13,821
| New | +$359K | ﹤0.01% | 8793 |
|
Susquehanna International Group's APLT Position: Q1 2026 in Review
Susquehanna International Group sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 52,692 shares — an estimated $5.27K sold.
Susquehanna International Group first reported a position in APLT in Q3 2020 and held it in 19 quarters. The position peaked at $3.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Susquehanna International Group reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 52,692 Applied Therapeutics shares in Q1 2026, an estimated $5.27K.
- Susquehanna International Group first reported a position in Applied Therapeutics in Q3 2020 and held it in 19 quarters.
- Susquehanna International Group's Applied Therapeutics position peaked at $3.3M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.